MULTIPLE-DOSE ACETAMINOPHEN PHARMACOKINETICS

被引:29
作者
SAHAJWALLA, CG [1 ]
AYRES, JW [1 ]
机构
[1] OREGON STATE UNIV, COLL PHARM, CORVALLIS, OR 97331 USA
关键词
D O I
10.1002/jps.2600800911
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Four different treatments of acetaminophen (Tylenol) were administered in multiple doses to eight healthy volunteers. Each treatment (325, 650, 825, and 1000 mg) was administered five times at 6-h intervals. Saliva acetaminophen concentration versus time profiles were determined. Noncompartmental pharmacokinetic parameters were calculated and compared to determine whether acetaminophen exhibited linear or dose-dependent pharmacokinetics. For doses less-than-or-equal-to 18 mg/kg, area under the curve (AUC), half-life (t1/2), mean residence time (MRT), and ratio of AUC to dose for the first dose were compared with the last dose. No statistically significant differences were observed in dose-corrected AUC for the first or last dose among subjects or treatments. Half-lives and MRT were not significantly different among treatments for the first or the last dose. Statistically significant differences in t1/2 and MRT were noted (p < 0.05) among subjects for the last dose. A plot of AUC versus dose for the first and the last doses exhibited a linear relationship. Dose-corrected saliva concentration versus time curves for the treatments were superimposable. Thus, acetaminophen exhibits linear pharmacokinetics for doses of 18 mg/kg or less. Plots of AUC versus dose for one subject who received doses higher than 18 mg/kg were curved, suggesting nonlinear behavior of acetaminophen in this subject.
引用
收藏
页码:855 / 860
页数:6
相关论文
共 30 条
  • [1] A COMPARATIVE-STUDY OF SALIVA AND SERUM PARACETAMOL LEVELS USING A SIMPLE SPECTROPHOTOMETRIC METHOD
    ADITHAN, C
    THANGAM, J
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (01) : 107 - 109
  • [2] FORMULATION AND EVALUATION OF SUSTAINED-RELEASE PARACETAMOL TABLETS
    AHMED, M
    ENEVER, RP
    [J]. JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1981, 6 (01): : 27 - 38
  • [3] PHARMACOKINETICS OF ORALLY-ADMINISTERED ACETAMINOPHEN IN MAN
    ALBERT, KS
    SEDMAN, AJ
    WAGNER, JG
    [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (05): : 381 - 393
  • [4] ABSOLUTE AND RELATIVE BIOAVAILABILITY OF ORAL ACETAMINOPHEN PREPARATIONS
    AMEER, B
    DIVOLL, M
    ABERNETHY, DR
    GREENBLATT, DJ
    SHARGEL, L
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (08) : 955 - 958
  • [5] ISOLATION AND IDENTIFICATION OF PARACETAMOL METABOLITES
    ANDREWS, RS
    BOND, CC
    BURNETT, J
    SAUNDERS, A
    WATSON, K
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1976, 4 : 34 - 39
  • [6] Beaver W T, 1966, Am J Med Sci, V251, P576
  • [7] SINGLE DOSE BIOAVAILABILITY OF ACETAMINOPHEN FOLLOWING ORAL-ADMINISTRATION
    BORIN, MT
    AYRES, JW
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 54 (03) : 199 - 209
  • [8] BRODIE BB, 1949, J PHARMACOL EXP THER, V97, P58
  • [9] ESTIMATION OF HEPATIC 1ST-PASS EFFECT OF ACETAMINOPHEN IN HUMANS AFTER ORAL-ADMINISTRATION
    CHIOU, WL
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (10) : 1734 - 1735
  • [10] CLEMENTS JA, 1978, CLIN PHARMACOL THER, V24, P420